New Canadian procedure could revolutionize AFib treatment

A novel Canadian procedure targeting atrial fibrillation (AFib) treatment could potentially revolutionize the way this common heart rhythm condition is managed. AFib, the most prevalent arrhythmia, affects one to two percent of the general population and can lead to severe health consequences like stroke or heart failure.

Jon Davies, an Edmonton resident, experienced fatigue and sudden loss of interest in physical activities like hiking and squash, symptoms that prompted him to seek medical attention. Initially, Davies was diagnosed with AFib and prescribed blood thinners, with no surgical options available due to significant enlargement of his heart. The status quo of medication was the only viable treatment option he had been offered.

The new Canadian approach aims to treat AFib through a two-part robotic technique. The first part involves ablations or the creation of tiny scars outside the heart using minimally invasive robotic surgery and catheter technology. This method allows for more dexterity and broader treatment of the heart area compared to traditional catheter ablation, which involves sedation and the insertion of tubes into the groins to pass wires into the heart and stop the flow of faulty signals.

The second part of the procedure involves a catheter going inside the heart to further treat the affected areas. This Canadian-first approach could potentially increase long-term success rates to 70 to 80 percent in patients with long-standing persistent atrial fibrillation, according to Dr. Paul Angaran, the cardiac arrhythmia director at St. Michael's Hospital in Toronto.